Literature DB >> 19117135

Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.

Jürgen Beer1, Claudia Christina Wagner, Markus Zeitlinger.   

Abstract

Plasma protein binding of antimicrobial agents is considered to be a key characteristic of antibiotics as it affects both their pharmacokinetics and pharmacodynamics. However, up to the present, no standard methods for measuring protein binding or for quantification of the influence of protein binding on antimicrobial activity exist. This short-coming has previously led to conflicting results on antibacterial activity of highly protein-bound antibiotics. The present review, therefore, set out to summarize (1) methods for quantification of protein binding, (2) microbiological growth media used for determination of the impact of protein binding on antimicrobial activity of antibiotics, and (3) different pharmacodynamic in vitro studies that are used in this context. The advantages and disadvantages of a wide range of different approaches are discussed and compared. The urgent call for international standardization by microbiological societies and laboratories may be considered as a logical consequence of the presented data.

Mesh:

Substances:

Year:  2009        PMID: 19117135      PMCID: PMC2664873          DOI: 10.1208/s12248-008-9072-1

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  75 in total

Review 1.  [Methods of determination and theoretical principles of the serum protein binding of drugs (author's transl)].

Authors:  W Scholtan
Journal:  Arzneimittelforschung       Date:  1978

2.  Measurement of the binding of antibiotics to ribosomal particles by means of equilibrium dialysis.

Authors:  H Teraoka; K H Nierhaus
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Protein binding of beta-lactams: the effects on activity and pharmacology particularly tissue penetration. I.

Authors:  R Wise
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

4.  Protein binding of beta-lactams: the effects on activity and pharmacology particularly tissue penetration. II. Studies in man.

Authors:  R Wise
Journal:  J Antimicrob Chemother       Date:  1983-08       Impact factor: 5.790

5.  Clinical pharmacology: plasma protein binding of drugs.

Authors:  W E Lindup; M C Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-17

Review 6.  Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts.

Authors:  L R Peterson; D N Gerding
Journal:  Rev Infect Dis       Date:  1980 May-Jun

7.  Measurement of protein binding by ultracentrifugation.

Authors:  Y Matsushita; I Moriguchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-07       Impact factor: 1.645

8.  Ultrafiltration in serum protein binding determinations.

Authors:  J B Whitlam; K F Brown
Journal:  J Pharm Sci       Date:  1981-02       Impact factor: 3.534

9.  Effect of protein binding on antibiotic activity in vivo.

Authors:  D J Merrikin; J Briant; G N Rolinson
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

10.  Determination of ampicillin in serum by using simple ultrafiltration technique and liquid chromatographic analysis.

Authors:  J E Hutchins; K Tyczkowska; A L Aronson
Journal:  J Assoc Off Anal Chem       Date:  1986 Sep-Oct
View more
  23 in total

Review 1.  Protein binding: do we ever learn?

Authors:  Markus A Zeitlinger; Hartmut Derendorf; Johan W Mouton; Otto Cars; William A Craig; David Andes; Ursula Theuretzbacher
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

2.  A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.

Authors:  Sami Ullah; Peter Matzneller; Markus Zeitlinger; Uwe Fuhr; Max Taubert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-06       Impact factor: 3.000

3.  Comparative Plasma Pharmacokinetics of Ceftriaxone and Ertapenem in Normoalbuminemia, Hypoalbuminemia, and Albumin Replacement in a Sheep Model.

Authors:  Jayesh A Dhanani; Benjamin Ahern; Liad Lupinsky; Karen Jackson; Steven C Wallis; Mohd H Abdul-Aziz; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 4.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis).

Authors:  Robert Papp; Aleksandar Popovic; Nancy Kelly; Richard Tschirret-Guth
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

Review 6.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

7.  Armeniaspirol analogues with more potent Gram-positive antibiotic activity show enhanced inhibition of the ATP-dependent proteases ClpXP and ClpYQ.

Authors:  Michael G Darnowski; Taylor D Lanosky; Puneet Labana; Jordan T Brazeau-Henrie; Nicholas D Calvert; Mark H Dornan; Claudia Natola; André R Paquette; Adam J Shuhendler; Christopher N Boddy
Journal:  RSC Med Chem       Date:  2022-02-14

8.  An Overview of the Protein Binding of Cephalosporins in Human Body Fluids: A Systematic Review.

Authors:  C Jongmans; A E Muller; P Van Den Broek; B De Melo Cruz De Almeida; C Van Den Berg; J Van Oldenrijk; P K Bos; B C P Koch
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

9.  A Population Pharmacokinetic Analysis to Study the Effect of Extracorporeal Membrane Oxygenation on Cefepime Disposition in Children.

Authors:  Athena F Zuppa; Nicole R Zane; Ganesh Moorthy; Heidi J Dalton; Alan Abraham; Ron W Reeder; Joseph A Carcillo; Andrew R Yates; Kathleen L Meert; Robert A Berg; Anil Sapru; Peter Mourani; Daniel A Notterman; J Michael Dean; Marc R Gastonguay
Journal:  Pediatr Crit Care Med       Date:  2019-01       Impact factor: 3.624

10.  Prediction of Minocycline Activity in the Gut From a Pig Preclinical Model Using a Pharmacokinetic -Pharmacodynamic Approach.

Authors:  Quentin Vallé; Béatrice B Roques; Alain Bousquet-Mélou; David Dahlhaus; Felipe Ramon-Portugal; Véronique Dupouy; Delphine Bibbal; Aude A Ferran
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.